0001750019-19-000023.txt : 20190412
0001750019-19-000023.hdr.sgml : 20190412
20190412160735
ACCESSION NUMBER: 0001750019-19-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190411
FILED AS OF DATE: 20190412
DATE AS OF CHANGE: 20190412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Menzel Garry E
CENTRAL INDEX KEY: 0001556064
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38811
FILM NUMBER: 19746359
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 3545 JOHN HOPKINS COURT SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC.
CENTRAL INDEX KEY: 0001750019
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474152751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-5200
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_155509964116859.xml
FORM 4
X0306
4
2019-04-11
0
0001750019
TCR2 THERAPEUTICS INC.
TCRR
0001556064
Menzel Garry E
TCR2 THERAPEUTICS INC.
100 BINNEY STREET
CAMBRIDGE
MA
02142
1
1
0
0
President & CEO
Stock Option (Right to Buy)
16.11
2019-04-11
4
A
0
486106
0
A
2029-04-10
Common Stock
486106.0
486106
D
25% of this option shall vest and become exercisable on January 1, 2020, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
/s/ Margaret Siegel as Attorney-in-Fact
2019-04-12